| Value | ₹141.4 Cr |
|---|
BSE filing, NSE: THYROCARE. Summary written from the filing by ALFA Finder's alert engine.
Thyrocare Technologies Ltd: key numbers
- Share price
- ₹456.30
- Market cap
- ₹7,263 Cr
- Revenue (annual)
- ₹829.0 Cr
- Net profit (annual)
- ₹163.0 Cr
- P/E (TTM)
- 50.4×Sector 52.3×
- Promoter holding
- 51.02%-9.90% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thyrocare Technologies Ltd
All →Thyrocare Technologies Annual General Meeting
Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.
Thyrocare Technologies Earnings Call Transcript: Key Takeaways
Thyrocare reports robust 24% growth, pivoting from volume-led routine testing to specialized diagnostics under new management. High operational leverage is evident as PAT growth significantly outpaced revenue.
- Call
- Guides 20% growth
Thyrocare Technologies Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹270.8 Cr (+25.1%), EBITDA ₹89.3 Cr (33.0% margin), PAT before exceptions ₹60.2 Cr (+25.7%). Debt-free; NHL radiology divestment pending.
Thyrocare Technologies Results Update
Thyrocare Technologies reported Q2FY27 consolidated revenue of Rs 270.8 Cr, up 25.1% YoY, with PAT before exceptions of Rs 60.2 Cr. The press release also notes a Rs 45 Cr non-cash NHL impairment tied to a proposed divestment.
Thyrocare Technologies Q2 FY27 Results: Net Profit ₹15.2 Cr, Down 68.2% YoY
Thyrocare Technologies Ltd reported revenue from operations of ₹270.8 Cr (+25.1% YoY) and net profit of ₹15.2 Cr (-68.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹15.2 Cr · -68.2% YoY
Thyrocare Technologies Board Meeting Date
Thyrocare Technologies intimated that its Board meeting is scheduled for 29 Oct 2026 to consider Q2/H1 FY27 results. No financial figures or decisions are reported in this prior intimation.
Other merger & restructuring announcements
All →Ginni Filaments Merger & Restructuring
Ginni Filaments incorporated a wholly owned subsidiary, Ginni RSA (Pty) Ltd, in South Africa. The subsidiary will trade and distribute wet wipes internationally.
Skipper Merger & Restructuring Worth ₹0.48 Cr
Skipper Limited incorporated a wholly owned subsidiary, Skipper Gridtech Inc, in Texas, USA. The subsidiary's share capital is up to USD 50,000 (about Rs 0.48 Crore).
- Value
- ₹0.48 Cr
Asian Energy Services Merger & Restructuring
Asian Energy Services will participate in incorporating Asian Energy Foundation, a Section 8 non-profit company limited by guarantee, holding 49% control. No cash consideration or share subscription is involved.
Waaree Renewable Technologies Merger & Restructuring
Waaree Renewable completed transferring its entire stake in Waaree Green Data Centers to parent Waaree Energies. The company ceased to be a subsidiary from 30 October 2026.
Goodricke Group Merger & Restructuring Worth ₹5 Cr
Goodricke Group signed a non-binding MoU to sell its Barnesbeg Tea Estate for Rs. 5 Crore. Completion of the definitive sale is expected by January 2027.
- Value
- ₹5.00 Cr
JK Agri Genetics Merger & Restructuring Worth ₹19.8 Cr
JK Agri Genetics sells 5.28-acre leasehold land to Sai Life Sciences for ₹19.80 crore to strengthen cash flow. Board approved the transfer subject to regulatory clearance.
- Value
- ₹19.80 Cr